Law.com Subscribers SAVE 30%
Call 855-808-4530 or email [email protected] to receive your discount on a new subscription.
Supreme Court Limits Forum Shopping with Plavix Lawsuit Decision
Class action plaintiffs often aggregate their claims to sue a defendant based on that defendant's tortious course of conduct, on the basis that it has adversely affected all plaintiffs in a similar fashion. That's basically the textbook definition of a class-action lawsuit. But on June 19, the U.S. Supreme Court upended years of jurisprudence to hand corporations a gift: a far more stringent definition of specific jurisdiction that will force plaintiffs to bring suit in multiple state courts rather than join their claims to those in far-flung jurisdictions.
In Bristol-Myers Squibb Co. v. Superior Court of California, 2017 U.S. LEXIS 3873 (U.S. 6/19/17), the court held that a corporation that engages in a nationwide course of conduct cannot be sued in a state court by anyone not injured within that jurisdiction, unless the corporation has significant contacts there, such as conducting much of its business therein. Eight justices formed the majority, with only one, Sonya Sotomayor, dissenting.
The BMS case was brought by more than 600 users of the drug Plavix against its manufacturer, Bristol-Myers Squibb Co. (BMS), in state court in San Francisco. Eighty-six of the plaintiffs were California residents, but the remaining 592 plaintiffs were residents of 33 other states. All plaintiffs asserted 13 claims under California law, though none of the out-of-state plaintiffs had any relationship to California: They did not buy Plavix there, were not prescribed it there, were not treated with it there, etc. The claims included negligent misrepresentation, misleading advertising and other product–liablity-related causes of action.
This premium content is locked for Entertainment Law & Finance subscribers only
ENJOY UNLIMITED ACCESS TO THE SINGLE SOURCE OF OBJECTIVE LEGAL ANALYSIS, PRACTICAL INSIGHTS, AND NEWS IN ENTERTAINMENT LAW.
- Stay current on the latest information, rulings, regulations, and trends
- Includes practical, must-have information on copyrights, royalties, AI, and more
- Tap into expert guidance from top entertainment lawyers and experts
Already a have an account? Sign In Now Log In Now
For enterprise-wide or corporate acess, please contact Customer Service at [email protected] or 877-256-2473
Major Differences In UK, U.S. Copyright Laws
This article highlights how copyright law in the United Kingdom differs from U.S. copyright law, and points out differences that may be crucial to entertainment and media businesses familiar with U.S law that are interested in operating in the United Kingdom or under UK law. The article also briefly addresses contrasts in UK and U.S. trademark law.
Strategy vs. Tactics: Two Sides of a Difficult Coin
With each successive large-scale cyber attack, it is slowly becoming clear that ransomware attacks are targeting the critical infrastructure of the most powerful country on the planet. Understanding the strategy, and tactics of our opponents, as well as the strategy and the tactics we implement as a response are vital to victory.
The Article 8 Opt In
The Article 8 opt-in election adds an additional layer of complexity to the already labyrinthine rules governing perfection of security interests under the UCC. A lender that is unaware of the nuances created by the opt in (may find its security interest vulnerable to being primed by another party that has taken steps to perfect in a superior manner under the circumstances.
Removing Restrictive Covenants In New York
In Rockwell v. Despart, the New York Supreme Court, Third Department, recently revisited a recurring question: When may a landowner seek judicial removal of a covenant restricting use of her land?